Course Details

• This course takes an in-depth look at the new ultra short acting benzodiazepine sedative which was approved for use in the UK in dentistry in 2023.
• You will be presented with a short presentation followed by an assessment.
• If you achieve 80% or more, you pass the course and will receive a printable certificate to place in your CPD folder. If you do not pass, you will have the opportunity to review the content and retake the assessment when you feel confident.

Aims

This course aims to provide learners with knowledge and understanding relating to the new ultra short acting benzodiazepine sedative which was approve for use in the UK in dentistry in 2023.

Objectives

During this course learners will be able to:

• Understand the current safety data and applications of the new drug.
• Understand the current standards regarding the use of the new drug.

Learning Outcomes

After completing this course the learner will gain an understanding of:

• The current safety data and applications of the new drug.
• The current standards regarding the use of the new drug.

GDC Development Outcomes

C

Topics covered